How Your Body Processes a New Digestive Medication
Treatments studied
Part of Digestive system clinical trials.
This study tests a new tablet (4-MUST) designed to help with digestive function. Researchers want to understand how your body absorbs and processes this medication, whether food affects how it works, and whether it's safe and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old and of Caucasian descent
- Be in good overall health with no chronic diseases (kidney, liver, heart, digestive, or other major conditions)
- Have normal vital signs: blood pressure 99–129/70–89 mmHg, heart rate 60–89 beats per minute, body temperature 36.0–36.9°C
- Have a body mass index (BMI) between 18.5 and 30, weighing at least 55 kg if male or 45 kg if female
- Be willing to use effective birth control and not donate blood or participate in other trials for 3 months before and during the study
- Stop taking most medications, supplements, and herbs at least 2 weeks before screening, and avoid alcohol and caffeine for 7 days before the study drug is given
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called 4-MUST can safely reduce pain and digestive symptoms caused by chronic gallbladder problems. You'll take tablets for several weeks while researchers track how well the medicine works and any side effects.
This trial tests an investigational tablet for people with long-term gallbladder inflammation (chronic cholecystitis) or bile duct movement problems (biliary dyskinesia). It aims to see if the tablet reduces stomach pain and other digestive symptoms.
This study tests two different versions of a drug called Trimedat to see if they work the same way in the body. It is for healthy volunteers to understand how the drug is absorbed and if it is safe.
This trial tests whether a medication called Odeston helps people with chronic cholecystitis (long-term gallbladder inflammation without stones). It aims to see if the drug improves symptoms in real-world medical practice.
This early-stage study tests how a new experimental medicine moves through and leaves the body in healthy volunteers. Researchers will compare different forms of the medicine to understand which works best and is safest.
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
Hear when a new Chronic Cholecystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.